WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world’s leading pharmaceutical and biotechnology companies, announced today that it will issue its financial results for the fourth quarter and year ended December 31, 2006 on Monday, March 19, 2007 before the opening of the stock market, with an accompanying conference call that day at 11:00 A.M. ET.
